Cardiac Biomarkers Testing Market Trends, Scope, Growth, Size, Powerful, Segmentation, Scenario, Forecast by 2030

According to the World Health Organization, approximately 4.77 million people in India suffer from cardiovascular diseases, with obesity causing angina pectoris in approximately 3.1% of the population. To reduce the burden of disease, the Government of India is launching a number of initiatives to raise awareness in rural areas. Several government and private healthcare institutes and diagnostic laboratories are implementing cardiac biomarkers diagnostic test kits to meet the growing patient population.
Data Bridge Market Research analyses that the cardiac biomarkers testing market which is USD 12098.97 million in 2022, is expected to reach USD 28491.13 million by 2030, at a CAGR of 11.30% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework

Asceses Full report@ https://www.databridgemarketresearch.com/reports/global-cardiac-biomarkers-testing-market

Gloabl cardiac biomarkers testing market is segmented on the basis of type, application and location of testing. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
• Myocardial muscle Creatine Kinase (CK-MB)
• Troponins (T and I)
• Myoglobin, Brain Natriuretic Peptide (BNPs)
• NT-proBNP
• Ischemia Modified Albumin (IMA)
Application
• Myocardial Infarction
• Congestive Heart Failure
• Acute Coronary Syndrome
• Atherosclerosis
Location of Testing
• Point of Care
• Laboratory

Related Report @-
https://databridgeshilp.blogspot.com/2024/02/cannula-market-trends-scope-growth-size.html
https://databridgeshilp.blogspot.com/2024/02/capecitabine-market-trends-scope-growth.html
https://databridgeshilp.blogspot.com/2024/02/capsule-endoscopy-market-trends-scope.html
https://databridgeshilp.blogspot.com/2024/02/cardiac-biomarkers-testing-market.html

Some of the major players operating in the cardiac biomarkers testing market are:
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Thermo Fisher Scientific Inc. (U.S.)
• Abbott (U.S.)
• QIAGEN (Germany)
• PerkinElmer, Inc. (U.S.)
• Merck KGaA (Germany)
• Bio-Rad Laboratories, Inc. (U.S.)
• Enzo Biochem, Inc. (U.S.)
• Charles River Laboratories (U.S.)
• Eurofins Scientific (Luxembourg)
• Agilent Technologies, Inc. (U.S.)
• Bruker (U.S.)
• Siemens (Germany)
• Epigenomics AG (Germany)
• General Electric (U.S.)

Contact Us:-
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

This release was published on openPR.